IK7

Ridinilazole

Created:	2022-03-25
Last modified:	2023-03-29

Find Related PDB Entry
1 entries where IK7 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	46
Chiral Atom Count	0
Bond Count	51
Aromatic Bond Count	32

2D diagram of IK7

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	Ridinilazole
Synonyms	2-pyridin-4-yl-5-(2-pyridin-4-yl-1H-benzimidazol-5-yl)-1H-benzimidazole
Systematic Name (OpenEye OEToolkits)	2-pyridin-4-yl-5-(2-pyridin-4-yl-1~{H}-benzimidazol-5-yl)-1~{H}-benzimidazole
Formula	C₂₄ H₁₆ N₆
Molecular Weight	388.424
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	[nH]1c2ccc(cc2nc1c3ccncc3)c4ccc5[nH]c(nc5c4)c6ccncc6
SMILES	OpenEye OEToolkits	2.0.7	c1cc2c(cc1c3ccc4c(c3)nc([nH]4)c5ccncc5)nc([nH]2)c6ccncc6
Canonical SMILES	CACTVS	3.385	[nH]1c2ccc(cc2nc1c3ccncc3)c4ccc5[nH]c(nc5c4)c6ccncc6
Canonical SMILES	OpenEye OEToolkits	2.0.7	c1cc2c(cc1c3ccc4c(c3)nc([nH]4)c5ccncc5)nc([nH]2)c6ccncc6
InChI	InChI	1.06	InChI=1S/C24H16N6/c1-3-19-21(29-23(27-19)15-5-9-25-10-6-15)13-17(1)18-2-4-20-22(14-18)30-24(28-20)16-7-11-26-12-8-16/h1-14H,(H,27,29)(H,28,30)
InChIKey	InChI	1.06	UHQFBTAJFNVZIV-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB15308
Name	Ridinilazole
Groups	investigational
Description	Ridinilazole is under investigation in clinical trial NCT02092935 (A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)).
Synonyms	Ridinilazole
Categories	Anti-Bacterial Agents Anti-Infective Agents Heterocyclic Compounds, Fused-Ring
CAS number	308362-25-6

Related Resource References

Resource Name	Reference
PubChem	16659285
ChEMBL	CHEMBL3753858

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.